Sarepta Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 5 | $0.01 | $0.01 | $0.01 |
| Q2 2024 | 5 | -$0.14 | -$0.12 | -$0.13 |
| Q3 2024 | 3 | -$0.07 | -$0.05 | -$0.06 |
| Q4 2024 | 9 | $0.93 | $1.95 | $1.54 |
| Q1 2025 | 5 | $2.01 | $2.54 | $2.29 |
| Q2 2025 | 4 | $2.57 | $3.18 | $2.89 |
| Q3 2025 | 4 | $2.71 | $3.36 | $3.05 |
| Q4 2025 | 4 | $3.06 | $3.78 | $3.44 |
| Q1 2026 | 3 | $2.85 | $3.52 | $3.20 |
| Q2 2026 | 3 | $2.83 | $3.50 | $3.18 |
| Q3 2026 | 3 | $2.81 | $3.47 | $3.15 |
| Q4 2026 | 3 | $2.75 | $3.40 | $3.09 |
Sarepta Therapeutics, Inc. Earnings Date And Information
Sarepta Therapeutics, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $0.62 earnings per share for the quarter, topping analysts' consensus estimates of $-0.15 by $0.77. The company had revenue of 467.17 M for the quarter and had revenue of 1.24 B for the year. Sarepta Therapeutics, Inc. has generated $-6 earnings per share over the last year ($-5.8 diluted earnings per share) and currently has a price-to-earnings ratio of 89.43. Sarepta Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Sarepta Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$0.15 | $0.35 | 0.5 | $407.17 M | $467.17 M |
| 08/07/2024 | Q2 2024 | $0.01 | $0.07 | 0.06 | $394.38 M | $362.93 M |
| 05/01/2024 | Q1 2024 | $0.10 | $0.38 | 0.28 | $413.46 M | |
| 02/28/2024 | Q4 2023 | $0.01 | $0.49 | 0.48 | $396.78 M | |
| 11/01/2023 | Q3 2023 | -$1.66 | -$0.46 | 1.2 | $285.33 M | $331.82 M |
| 08/02/2023 | Q2 2023 | -$1.89 | -$0.27 | 1.62 | $255.99 M | $261.24 M |
| 05/02/2023 | Q1 2023 | -$1.46 | -$5.86 | -4.4 | $253.50 M | |
| 02/28/2023 | Q4 2022 | -$1.28 | -$1.24 | 0.04 | $258.43 M | |
| 11/02/2022 | Q3 2022 | -$1.21 | -$2.94 | -1.73 | $234.52 M | $230.27 M |
| 08/02/2022 | Q2 2022 | -$1.07 | -$2.65 | -1.58 | $220.81 M | $233.49 M |
| 05/04/2022 | Q1 2022 | -$1.35 | -$1.20 | 0.15 | $210.83 M | |
| 03/01/2022 | Q4 2021 | -$1.51 | -$1.53 | -0.02 | $201.46 M | |
| 11/03/2021 | Q3 2021 | -$1.86 | -$0.60 | 1.26 | $178.89 M | $189.41 M |
| 08/04/2021 | Q2 2021 | -$1.03 | -$1.02 | 0.01 | $167.07 M | $164.09 M |
| 05/05/2021 | Q1 2021 | -$2.01 | -$2.10 | -0.09 | $146.93 M | |
| 03/01/2021 | Q4 2020 | -$2.00 | -$2.41 | -0.41 | $145.14 M | |
| 11/05/2020 | Q3 2020 | -$1.89 | -$2.50 | -0.61 | $137.76 M | $143.92 M |
| 08/05/2020 | Q2 2020 | -$1.81 | -$1.93 | -0.12 | $115.66 M | $137.36 M |
| 05/06/2020 | Q1 2020 | -$2.29 | -$0.23 | 2.06 | $113.67 M | |
| 02/26/2020 | Q4 2019 | -$1.83 | -$3.16 | -1.33 | $100.11 M |
Sarepta Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Sarepta Therapeutics, Inc.'s earnings date?
Sarepta Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did Sarepta Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Sarepta Therapeutics, Inc. (:SRPT) reported $0.62 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.15 by $0.77.
-
How can I listen to Sarepta Therapeutics, Inc.'s earnings conference call?
The conference call for Sarepta Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Sarepta Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Sarepta Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Sarepta Therapeutics, Inc. generate each year?
Sarepta Therapeutics, Inc. (:SRPT) has a recorded annual revenue of $1.24 B.
-
How much profit does Sarepta Therapeutics, Inc. generate each year?
Sarepta Therapeutics, Inc. (:SRPT) has a recorded net income of $1.24 B. Sarepta Therapeutics, Inc. has generated $-5.8 earnings per share over the last four quarters.
-
What is Sarepta Therapeutics, Inc.'s price-to-earnings ratio?
Sarepta Therapeutics, Inc. (:SRPT) has a price-to-earnings ratio of 89.43 and price/earnings-to-growth ratio is 0.53.
